MX393880B - Co-cristales de compuestos de glicina sustituida y usos de los mismos. - Google Patents
Co-cristales de compuestos de glicina sustituida y usos de los mismos.Info
- Publication number
- MX393880B MX393880B MX2019009616A MX2019009616A MX393880B MX 393880 B MX393880 B MX 393880B MX 2019009616 A MX2019009616 A MX 2019009616A MX 2019009616 A MX2019009616 A MX 2019009616A MX 393880 B MX393880 B MX 393880B
- Authority
- MX
- Mexico
- Prior art keywords
- crystals
- substituted glycine
- glycine compounds
- compound
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/15—Fumaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/430,750 US9877942B1 (en) | 2017-02-13 | 2017-02-13 | Co-crystals of substituted glycine and uses thereof |
| PCT/CN2018/072186 WO2018145553A1 (en) | 2017-02-13 | 2018-01-11 | Co-crystals of substituted glycine compounds and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019009616A MX2019009616A (es) | 2019-10-14 |
| MX393880B true MX393880B (es) | 2025-03-24 |
Family
ID=61005084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019009616A MX393880B (es) | 2017-02-13 | 2018-01-11 | Co-cristales de compuestos de glicina sustituida y usos de los mismos. |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US9877942B1 (enExample) |
| EP (1) | EP3579828B1 (enExample) |
| JP (2) | JP2020507567A (enExample) |
| KR (1) | KR20190118574A (enExample) |
| CN (1) | CN110520117A (enExample) |
| CA (1) | CA3051284A1 (enExample) |
| IL (1) | IL268220B (enExample) |
| MX (1) | MX393880B (enExample) |
| RU (1) | RU2019128576A (enExample) |
| TW (1) | TWI670058B (enExample) |
| WO (1) | WO2018145553A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2936094T3 (es) | 2016-06-13 | 2023-03-14 | Syneurx Int Taiwan Corp | Cocristales de benzoato de sodio y usos de los mismos |
| US9877942B1 (en) | 2017-02-13 | 2018-01-30 | Syneurx International (Taiwan) Corp. | Co-crystals of substituted glycine and uses thereof |
| CN113233976B (zh) * | 2021-05-08 | 2021-11-16 | 广州萃普生物科技有限公司 | 一种没食子酸和氨基乙酸共晶及含有该共晶的美白膏霜 |
| EP4419499A1 (en) | 2021-10-20 | 2024-08-28 | Purac Biochem B.V. | Co-crystal of citric acid and glycine and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1073432E (pt) * | 1998-04-14 | 2007-10-22 | Gen Hospital Corp | Utilização da d-alanina ou da d-serina para o tratamento da esquizofrenia |
| EP1727520A2 (en) * | 2003-12-09 | 2006-12-06 | Medcrystalforms, Llc | Method of preparation of mixed phase co-crystals with active agents |
| US20100204204A1 (en) * | 2007-06-06 | 2010-08-12 | University Of South Florida | Nutraceutical co-crystal compositions |
| WO2009018368A1 (en) * | 2007-07-30 | 2009-02-05 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Combination treatment of nmda (n-methyl-d-aspartate)-enhancer, glycine transporter inhibitor, d-amino acid oxidase inhibitor (daaoi) for neuropsychiatric disorders |
| GB201411802D0 (en) * | 2014-07-02 | 2014-08-13 | Univ Bradford | Effervescent compositions |
| US9877942B1 (en) | 2017-02-13 | 2018-01-30 | Syneurx International (Taiwan) Corp. | Co-crystals of substituted glycine and uses thereof |
-
2017
- 2017-02-13 US US15/430,750 patent/US9877942B1/en active Active
-
2018
- 2018-01-09 US US15/866,303 patent/US10328041B2/en active Active
- 2018-01-11 WO PCT/CN2018/072186 patent/WO2018145553A1/en not_active Ceased
- 2018-01-11 RU RU2019128576A patent/RU2019128576A/ru unknown
- 2018-01-11 CN CN201880011387.7A patent/CN110520117A/zh active Pending
- 2018-01-11 TW TW107101039A patent/TWI670058B/zh active
- 2018-01-11 CA CA3051284A patent/CA3051284A1/en active Pending
- 2018-01-11 JP JP2019542698A patent/JP2020507567A/ja active Pending
- 2018-01-11 KR KR1020197023303A patent/KR20190118574A/ko not_active Ceased
- 2018-01-11 MX MX2019009616A patent/MX393880B/es unknown
- 2018-01-11 EP EP18751659.6A patent/EP3579828B1/en active Active
- 2018-04-03 US US15/944,722 patent/US10328042B2/en active Active
-
2019
- 2019-05-15 US US16/412,804 patent/US10765651B2/en active Active
- 2019-07-22 IL IL268220A patent/IL268220B/en unknown
-
2023
- 2023-03-29 JP JP2023053835A patent/JP7723991B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| TWI670058B (zh) | 2019-09-01 |
| IL268220B (en) | 2022-04-01 |
| JP7723991B2 (ja) | 2025-08-15 |
| US20180228753A1 (en) | 2018-08-16 |
| EP3579828B1 (en) | 2025-03-26 |
| US20190262299A1 (en) | 2019-08-29 |
| WO2018145553A1 (en) | 2018-08-16 |
| US20180228754A1 (en) | 2018-08-16 |
| JP2020507567A (ja) | 2020-03-12 |
| CA3051284A1 (en) | 2018-08-16 |
| EP3579828A1 (en) | 2019-12-18 |
| EP3579828A4 (en) | 2020-11-18 |
| IL268220A (en) | 2019-09-26 |
| MX2019009616A (es) | 2019-10-14 |
| RU2019128576A (ru) | 2021-03-15 |
| TW201840308A (zh) | 2018-11-16 |
| JP2023082101A (ja) | 2023-06-13 |
| RU2019128576A3 (enExample) | 2021-05-14 |
| CN110520117A (zh) | 2019-11-29 |
| US10765651B2 (en) | 2020-09-08 |
| US10328041B2 (en) | 2019-06-25 |
| US9877942B1 (en) | 2018-01-30 |
| KR20190118574A (ko) | 2019-10-18 |
| US10328042B2 (en) | 2019-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2021001330A1 (es) | Nuevos compuestos heterocíclicos | |
| ECSP18083519A (es) | Inhibidores de bromodominios | |
| CR20170237A (es) | Nuevos compuestos de 5-amino-6h-tiazolo[4,5-d]pirimidin-2,7-diona 3-sustituidos para el tratamiento y profilaxis de infecciones virales. | |
| CU24572B1 (es) | Compuestos derivados de 1,2,4-triazolonas 2,4,5-trisustituidas | |
| CO2018012946A2 (es) | Moduladores de la vía de estrés integrada | |
| MX376106B (es) | Nuevas piridazonas y triazinonas para el tratamiento y la profilaxis de infección por virus de hepatitis b. | |
| MX2018007774A (es) | Compuestos heterociclicos como inmunomoduladores. | |
| ECSP20030074A (es) | Nuevos profármacos de catecolamina para uso en el tratamiento de la enfermedad de parkinson | |
| CO2017007355A2 (es) | Compuestos derivados de pirazincarbozamida y de pirazincarboxilato para el tratamiento de la infección por el virus de hepatitis b | |
| MX388749B (es) | Compuestos de imidazo-piperidina fusionada que contienen una amida heterocíclica de 4 miembros como inhibidores de jak. | |
| UY33357A (es) | Uracilos herbicidas | |
| MX375424B (es) | Derivados de 1,1,1-trifluoro-3-hidroxipropan-2-il carbamato y derivados de 1,1,1-trifluoro-4- hidroxibutan-2-il carbamato como inhibidores de magl | |
| UY32098A (es) | Heteroarilos sustituidos | |
| CR20170392A (es) | Compuestos bicíclicos de sulfonamida cetona | |
| CO6460766A2 (es) | Compuestos de haloalquil heteroaril benzamida | |
| MX391221B (es) | Compuestos y composiciones y usos de los mismos. | |
| CL2018000375A1 (es) | 2-amino-3-fluoro-3-(fluorometil)-6-meti-6-fenil-3,4,5,6-tetrahidropiridinas como inhibidores de bace1. | |
| MX393880B (es) | Co-cristales de compuestos de glicina sustituida y usos de los mismos. | |
| MX386616B (es) | Compuestos de carfilzomib pegilados. | |
| CL2017002745A1 (es) | Nuevos compuestos y derivados de sulfonimidoilpurinona para el tratamiento y profilaxis de infecciones víricas | |
| CU24608B1 (es) | Compuestos de dihidrooxadiazinonas sustituidas útiles en el tratamiento de enfermedades hiperproliferativas y métodos para preparar dichos compuestos | |
| PE20170439A1 (es) | Derivados de bis(aril)catecol como herbicidas | |
| AR109022A1 (es) | Mezclas activas como plaguicidas | |
| CO2021001277A2 (es) | Inhibidores de triazol glicolato oxidasa | |
| EP3820980A4 (en) | ESTERQUAT COMPOSITIONS |